Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2
Journal
Pediatric Emergency Care
ISSN
1535-1815
0749-5161
Date Issued
2020
Author(s)
Raúl Bustos B
Juan Camilo Jaramillo-Bustamante
Pablo Vasquez-Hoyos
Pablo Cruces
Type
Resource Types::text::journal::journal article
URL Institutional Repository
Subjects
hyperinflammatory syndrome
;
pims-ts
;
mis-c
;
kawasaki
;
covid-19
;
adrenal cortex hormones
;
anti-bacterial agents
;
anticoagulants
;
child
;
combined modality therapy
;
covid-19
;
female
;
humans
;
immunoglobulins, intravenous
;
immunosuppressive agents
;
intensive care units, pediatric
;
length of stay
;
male
;
mucocutaneous lymph node syndrome
;
myocarditis
;
sars-cov-2
;
systemic inflammatory response syndrome
;
acetylsalicylic acid
;
albumin
;
anakinra
;
antibiotic agent
;
anticoagulant agent
;
c reactive protein
;
d dimer
;
ferritin
;
immunoglobulin
;
infliximab
;
procalcitonin
;
siltuximab
;
steroid
;
tocilizumab
;
vasoactive agent
;
antiinfective agent
;
corticosteroid
;
immunoglobulin
;
immunosuppressive agent
;
acute kidney failure
;
case study
;
child
;
childhood mortality
;
clinical feature
;
conjunctivitis
;
embase
;
extracorporeal oxygenation
;
female
;
fever
;
gastrointestinal symptom
;
high flow nasal cannula therapy
;
human
;
invasive ventilation
;
laboratory test
;
length of stay
;
lymphocyte count
;
lymphocytopenia
;
male
;
medline
;
mucocutaneous lymph node syndrome
;
myocarditis
;
neurologic disease
;
noninvasive ventilation
;
pediatric intensive care unit
;
pediatric multisystem inflammatory syndrome
;
platelet count
;
quantitative analysis
;
rash
;
renal replacement therapy
;
respiratory tract disease
;
review
;
school child
;
shock
;
systematic review
;
complication
;
mucocutaneous lymph node syndrome
;
multimodality cancer therapy
;
myocarditis
;
systemic inflammatory response syndrome
;
therapy